Paid Clinical Trials Tallahassee
Discover 96 paid clinical trials in Tallahassee, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSDMulti-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Sponsor:
The University of Texas at Dallas
Location:
Code:
NCT03932773
Conditions
Post Traumatic Stress Disorder
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Active rTMS
Sham rTMS
Cognitive Processing Therapy
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312176
Conditions
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Paclitaxel
Nab-paclitaxel
Capecitabine
MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims StudyMILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study
Sponsor:
Vertos Medical, Inc.
Location:
Code:
NCT03072927
Conditions
Lumbar Spinal Stenosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MILD
Interspinous Process Decompression
Dysarthria Management for Minor GroupsDysarthria Management for Minor Groups
Sponsor:
Florida State University
Location:
Code:
NCT06593860
Conditions
Parkinson Disease
Dysarthria
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
Remote speech rehabilitation
SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTNSPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN
Sponsor:
Medtronic Vascular
Location:
Code:
NCT05198674
Conditions
Hypertension
Vascular Diseases
Cardiovascular Diseases
Chronic Kidney Diseases
Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Renal Denervation (Symplicity Spyral™)
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral RegurgitationClinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Sponsor:
Abbott Medical Devices
Location:
Code:
NCT03433274
Conditions
Mitral Regurgitation
Mitral Insufficiency
Mitral Valve Insufficiency
Cardiovascular Diseases
Valve Disease, Heart
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tendyne Mitral Valve System
MitraClip System
The Goal of This Project is to Pilot Test a Program Designed to Address the Needs of Targets of Peer Victimization in Grades 6-12. the Name of the Program Will Be IVY (Intervention for Victimized Youth).The Goal of This Project is to Pilot Test a Program Designed to Address the Needs of Targets of Peer Victimization in Grades 6-12. the Name of the Program Will Be IVY (Intervention for Victimized Youth).
Sponsor:
Florida State University
Location:
Code:
NCT06631274
Conditions
Victimization
Eligibility Criteria
Sex: All
Age: 11 - 14
Healthy Volunteers: Not accepted
Interventions
counseling
Study With Various Immunotherapy Treatments in Participants With Lung CancerStudy With Various Immunotherapy Treatments in Participants With Lung Cancer
Sponsor:
Gilead Sciences
Location:
Code:
NCT05676931
Conditions
Advanced Non-Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Domvanalimab
Quemliclustat
Zimberelimab
Docetaxel
Platinum-Based Doublet
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaPROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Sponsor:
LimFlow, Inc.
Location:
Code:
NCT05313165
Conditions
Critical Limb Ischemia
Chronic Limb-Threatening Ischemia
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
LimFlow Stent Graft System
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05963074
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ibrutinib
Venetoclax